top of page

HELP 4 HD INTERNATIONAL

Stand Up Speak Up 4 HD 🎉 Click Here

Search

Wave Life Sciences Announces Positive Results from Phase 1b/2a SELECT-HD Trial with First Clinical Demonstration of Allele-Selective Mutant Huntingtin Lowering in Huntington’s Disease

katie8288

Jun 25, 2024

0 min read

Recent Posts

Living at Risk: Navigating Life with Huntington's Disease in the Family

Living at Risk: Navigating Life with Huntington's Disease in the Family

Skyhawk Therapeutics Announces Final Fifteen-Month Results from Phase 1/2 Clinical Trial of SKY-0515 in Huntington’s Disease Patients

Skyhawk Therapeutics Announces Final Fifteen-Month Results from Phase 1/2 Clinical Trial of SKY-0515 in Huntington’s Disease Patients

Prilenia Appoints Frederick (Rick) Munschauer, MD, FAAN, as Chief Medical Officer

Prilenia Appoints Frederick (Rick) Munschauer, MD, FAAN, as Chief Medical Officer

Comments

bottom of page